Coya Therapeutics (COYA) Competitors $5.51 +0.06 (+1.10%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$5.54 +0.03 (+0.45%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COYA vs. SNDL, AUTL, RLAY, RAPP, ERAS, SANA, UPB, PHAT, CKPT, and KMDAShould you be buying Coya Therapeutics stock or one of its competitors? The main competitors of Coya Therapeutics include SNDL (SNDL), Autolus Therapeutics (AUTL), Relay Therapeutics (RLAY), Rapport Therapeutics (RAPP), Erasca (ERAS), Sana Biotechnology (SANA), Upstream Bio (UPB), Phathom Pharmaceuticals (PHAT), Checkpoint Therapeutics (CKPT), and Kamada (KMDA). These companies are all part of the "pharmaceutical products" industry. Coya Therapeutics vs. SNDL Autolus Therapeutics Relay Therapeutics Rapport Therapeutics Erasca Sana Biotechnology Upstream Bio Phathom Pharmaceuticals Checkpoint Therapeutics Kamada SNDL (NASDAQ:SNDL) and Coya Therapeutics (NASDAQ:COYA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, community ranking, media sentiment, dividends and profitability. Does the MarketBeat Community believe in SNDL or COYA? SNDL received 118 more outperform votes than Coya Therapeutics when rated by MarketBeat users. However, 95.83% of users gave Coya Therapeutics an outperform vote while only 71.94% of users gave SNDL an outperform vote. CompanyUnderperformOutperformSNDLOutperform Votes14171.94% Underperform Votes5528.06% Coya TherapeuticsOutperform Votes2395.83% Underperform Votes14.17% Do analysts prefer SNDL or COYA? SNDL presently has a consensus price target of $3.63, indicating a potential upside of 172.56%. Coya Therapeutics has a consensus price target of $17.00, indicating a potential upside of 208.53%. Given Coya Therapeutics' higher probable upside, analysts clearly believe Coya Therapeutics is more favorable than SNDL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Coya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, SNDL or COYA? SNDL has a beta of 3.23, indicating that its stock price is 223% more volatile than the S&P 500. Comparatively, Coya Therapeutics has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Do institutionals & insiders have more ownership in SNDL or COYA? 39.8% of Coya Therapeutics shares are owned by institutional investors. 9.8% of Coya Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is SNDL or COYA more profitable? Coya Therapeutics has a net margin of 0.00% compared to SNDL's net margin of -12.11%. SNDL's return on equity of -8.27% beat Coya Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SNDL-12.11% -8.27% -6.96% Coya Therapeutics N/A -31.63%-27.76% Which has stronger valuation and earnings, SNDL or COYA? Coya Therapeutics has lower revenue, but higher earnings than SNDL. Coya Therapeutics is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSNDL$920.45M0.38-$127.91M-$0.26-5.12Coya Therapeutics$3.55M25.93-$7.99M-$0.98-5.62 Does the media favor SNDL or COYA? In the previous week, SNDL had 11 more articles in the media than Coya Therapeutics. MarketBeat recorded 14 mentions for SNDL and 3 mentions for Coya Therapeutics. Coya Therapeutics' average media sentiment score of 1.16 beat SNDL's score of 0.63 indicating that Coya Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SNDL 6 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Coya Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCoya Therapeutics beats SNDL on 9 of the 17 factors compared between the two stocks. Remove Ads Get Coya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COYA vs. The Competition Export to ExcelMetricCoya TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$91.15M$6.33B$5.33B$7.57BDividend YieldN/A3.24%5.11%4.32%P/E Ratio-8.486.7921.7317.82Price / Sales25.93225.96379.2094.61Price / CashN/A65.6738.1534.64Price / Book2.235.866.464.00Net Income-$7.99M$141.86M$3.20B$247.23M7 Day Performance5.15%4.50%2.86%1.45%1 Month Performance-15.10%-12.65%-8.55%-6.24%1 Year Performance-32.56%-11.06%10.47%0.60% Coya Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COYACoya Therapeutics2.6272 of 5 stars$5.51+1.1%$17.00+208.5%-34.2%$91.15M$3.55M-8.486Positive NewsGap DownSNDLSNDL2.9292 of 5 stars$1.33-2.9%$3.63+172.6%-30.7%$349.49M$920.45M-4.29580AUTLAutolus Therapeutics2.2774 of 5 stars$1.31-1.5%$9.32+611.5%-71.4%$348.58M$10.12M-1.08330RLAYRelay Therapeutics2.5841 of 5 stars$2.05+2.5%$19.80+865.9%-59.6%$347.52M$10.01M-0.79330Gap DownHigh Trading VolumeRAPPRapport Therapeutics1.6783 of 5 stars$9.51+5.8%$35.00+268.0%N/A$347.08MN/A-0.69N/AShort Interest ↑High Trading VolumeERASErasca3.2915 of 5 stars$1.23+5.6%$4.83+294.6%-40.5%$347.00MN/A-1.48120Short Interest ↓SANASana Biotechnology2.2442 of 5 stars$1.53+3.4%$10.80+605.9%-80.1%$344.29MN/A-1.09380High Trading VolumeUPBUpstream BioN/A$6.36+4.3%$56.50+788.4%N/A$341.16M$2.37M0.0038Positive NewsPHATPhathom Pharmaceuticals3.7512 of 5 stars$4.87-0.2%$22.17+355.2%-52.4%$339.13M$55.25M-0.86110CKPTCheckpoint Therapeutics2.2218 of 5 stars$3.99-0.5%$4.33+8.6%+133.7%$335.89M$41,000.00-2.1710Positive NewsKMDAKamada3.7422 of 5 stars$5.84-2.5%$14.67+151.1%+22.6%$335.68M$160.95M20.86360Short Interest ↓Gap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies SNDL Competitors Autolus Therapeutics Competitors Relay Therapeutics Competitors Rapport Therapeutics Competitors Erasca Competitors Sana Biotechnology Competitors Upstream Bio Competitors Phathom Pharmaceuticals Competitors Checkpoint Therapeutics Competitors Kamada Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COYA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy COYA Stock Free COYA Stock Alerts